This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
tim.hodson Tue, 03/11/2025 - 11:19 Mar. 10, 2025-- Corcept Therapeutics Inc., tim.hodson Tue, 03/11/2025 - 11:19 Mar. 10, 2025-- Corcept Therapeutics Inc., will establish the prevalence of endogenous hypercortisolism in patients with resistant hypertension.
tim.hodson Mon, 03/10/2025 - 11:17 At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., The analysis of data from SCAARon the Prevail coronary paclitaxel drug-coated balloon (DCB) will be presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 in Washington, D.C.
tim.hodson Wed, 03/26/2025 - 14:25 March 17, 2025 Bayer recently announcedthat the U.S. 2 Most are balancing multiple comorbidities, such as obesity, diabetes, hypertension and chronic kidney disease (CKD). Accessed February 21, 2025. Accessed March 5, 2025. Accessed February 21, 2025. J Card Fail.
Circulation, Volume 151, Issue 10 , Page 716-732, March 11, 2025. Albuminuriaincreased urine albumin excretionis associated with cardiovascular mortality among patients with diabetes, hypertension, chronic kidney disease, or heart failure, as well as among adults with few cardiovascular risk factors.
On-demand access is available now and will remain open until December 2025. Diabetes Management: Gain insights into precision medicine, advanced insulin therapies, and continuous glucose monitoring (CGM) for cardiovascular risk assessment. When Will It Be Available?
Stroke, Volume 56, Issue Suppl_1 , Page AWP56-AWP56, February 1, 2025. The association remained significant after adjustment for age, race, gender, hypertension, diabetes, smoking status, education level and regular dental care use (Adjusted OR 0.61 The log WMH volume was higher (9.50.85
Stroke, Volume 56, Issue Suppl_1 , Page ATP146-ATP146, February 1, 2025. AIS hospitalizations were identified based on a primary diagnosis of ICD 10 CM code I63, and risk factors (RFs) (hypertension, diabetes, hyperlipidemia, and tobacco use) were identified using secondary diagnoses codes. vs. 82.6%, PR: 1.1).
tim.hodson Mon, 03/10/2025 - 11:17 At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., The analysis of data from SCAARon the Prevail coronary paclitaxel drug-coated balloon (DCB) will be presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 in Washington, D.C.
Stroke, Volume 56, Issue Suppl_1 , Page AWP319-AWP319, February 1, 2025. Reliability of self-reported risk factors was high in overweight (F1 0.81) and diabetes (F1 0.71), moderate in hearing impairment (F1 0.59) and hypertension (F1 0.56) and low in hypercholesterolemia (F1 0.49) and kidney disease (F1 0.25).
AHA announced a $12M investment in AI research, with an RFP slated for early 2025. Many of our CMHC faculty who spoke at AHA 2024 are featured in this on-demand program, sharing expertise on key topics in cardiorenal health, obesity, diabetes, dyslipidemia, atherosclerosis, and more. Read the published study. Watch AI-ECHO results.
Stroke, Volume 56, Issue Suppl_1 , Page ATP228-ATP228, February 1, 2025. Significant associations were found between recurrent ischemic events and hypertension (p=0.001), diabetes (p=0.033), and smoking (p=0.001). Smoking, hypertension, and diabetes were significant risk factors for recurrent ischemic events.
Stroke, Volume 56, Issue Suppl_1 , Page ATP136-ATP136, February 1, 2025. Collaboration between primary care centers and hospital staff was essential for the projects success by delivering personalized care and home monitoring devices to patients through access to a digital platform.
They had lower risks of hypertension, diabetes, dementia, stroke, Parkinson’s disease, obesity, sleep apnea, and other chronic health conditions compared to inactive adults and similar risks compared to adults accruing their weekly exercise in a greater number of days. 2025 Feb;35(2):e70024. Scand J Med Sci Sports.
Stroke, Volume 56, Issue Suppl_1 , Page ATP325-ATP325, February 1, 2025. We ran logistic regression models to estimate the associations of several cardiometabolic indicators with incident strokes after adjusting for age, diabetes, and hypertension. All analyses were conducted in R software (version 4.4.2)Results:The
Stroke, Volume 56, Issue Suppl_1 , Page ATP334-ATP334, February 1, 2025. Compared to WH, more BL and HS were comorbid with diabetes, hypertension, and prior stroke (p<0.05). Results:A total of 318 patients were identified with a median age of 43 and 57.5% male, covering 57.2% BL, and 20.4% BL was found to have 2.7
Attendees dove into cutting-edge topics, including FDA updates, resistant hypertension, and cardiac biomarkers. “I Florez, MD, PhD , explored the future of precision medicine in diabetes. The 20th Annual CMHC, an anniversary celebration, is already on the horizon, set for October 23-25, 2025, in Boston. Learn more now!
Stroke, Volume 56, Issue Suppl_1 , Page ATP48-ATP48, February 1, 2025. Over half of the subjects with strokes were females (55 (63.2%)), diabetic (44 (50.6%)), hypertensive (58 (66.7%)), and had metabolic syndrome (44 (50.6%)). Mixed linear models adjusted for age and education showed that diabetes (Beta: -1.4,
Stroke, Volume 56, Issue Suppl_1 , Page ATP170-ATP170, February 1, 2025. Introduction:Cerebrovascular white matter disease (WMD) severity is linked to vascular risk factors like hypertension, hyperlipidemia, and diabetes. Patients with high WMD burden were older, more often non-Hispanic, and had more hypertension (Table 1).
Stroke, Volume 56, Issue Suppl_1 , Page ATP106-ATP106, February 1, 2025. Hypertension, diabetes mellitus, current smoking and dyslipidaemia were not significantly associated with CogI.Conclusions:A significant proportion of young adult ischemic stroke survivors experience CogI. 34.4), episodic memory (18.5%; 95% CI 9.7-
Stroke, Volume 56, Issue Suppl_1 , Page ATP273-ATP273, February 1, 2025. At baseline, prevalence of comorbidities was high (hypertension 66% and 84%, hyperlipidemia 53% and 75%, coronary artery disease 18% and 31%, diabetes 25% and 38% in MarketScan and CDM, respectively). Mean age was 62 years in MarketScan and 72 years in CDM.
Stroke, Volume 56, Issue Suppl_1 , Page A49-A49, February 1, 2025. Hypertension, diabetes, hyperlipidemia, and chronic kidney disease are well-known cardiovascular risk factors for ICH. Introduction:Intracranial hemorrhage (ICH) is the most severe adverse effect of anticoagulation in atrial fibrillation (AF) patients.
Stroke, Volume 56, Issue Suppl_1 , Page ATP266-ATP266, February 1, 2025. Effective blood pressure (BP) management is crucial for reducing stroke and CVD risk, yet controlled hypertension remains suboptimal especially among minority populations. Background:Stroke is the 5thleading cause of death in the U.S. SD=15.8); 63.8%
Stroke, Volume 56, Issue Suppl_1 , Page AWP359-AWP359, February 1, 2025. years, 54% were women, 87% had hypertension, 44% had diabetes mellitus, and 54% had hyperlipidemia. Background:Mechanical thrombectomy has been associated with improved outcomes in patients with acute ischemic stroke. pg/ml vs. 39.520.6
Stroke, Volume 56, Issue Suppl_1 , Page AWP294-AWP294, February 1, 2025. Propensity score-matched analysis (PSM) (1:1) was performed on age, gender, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, LDL level, left ventricular ejection fraction and various drugs including beta blockers, ACEi and ARBi.
Stroke, Volume 56, Issue Suppl_1 , Page AWP266-AWP266, February 1, 2025. Clinically, 74.16% had hypertension, and 29.90% had diabetes. Background:Sleep apnea symptoms, such as snoring and breathing pauses, often co-occur with depression in stroke survivors, adversely affecting recovery and quality of life. 10.47; p=0.001).
Stroke, Volume 56, Issue Suppl_1 , Page AWP180-AWP180, February 1, 2025. Patients with confirmed CW were younger, predominantly female, and they were less likely to have history of hypertension and diabetes mellitus compared to those in the possible CW and no CW groups (Table 1).
Stroke, Volume 56, Issue Suppl_1 , Page AWP141-AWP141, February 1, 2025. In unadjusted analysis, factors significantly associated with troponin testing were a triage complaint of chest pain, older age, higher mean systolic BP, hypertension, diabetes, obesity, stroke or TIA, congestive heart failure, or coronary disease.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP94-AWMP94, February 1, 2025. There were significantly higher incidences in uncontrolled hypertension (28.2% vs 7.9%), diabetes (33.6% Interestingly, there was a trend towards increased co-morbidities in patients during this period, despite the improved outcomes.
Stroke, Volume 56, Issue Suppl_1 , Page ATP319-ATP319, February 1, 2025. Nearly half (47%) of graded census tracts had persistent discrimination and tracts with persistent discrimination were younger, less non-Hispanic white, and had higher proportions of diabetes, obesity and hypertension (Table).
Stroke, Volume 56, Issue Suppl_1 , Page ATP152-ATP152, February 1, 2025. Ensuring a follow-up neurology appointment within two weeks is vital to managing stroke risk factors like hypertension, diabetes, and atrial fibrillation. Early follow-up helps adjust treatment plans, reducing stroke recurrence.
Stroke, Volume 56, Issue Suppl_1 , Page ADP42-ADP42, February 1, 2025. Introduction:The transitional period from hospital discharge to the community for stroke survivors is a vulnerable time as patients navigate healthcare systems with their new impairments.
Stroke, Volume 56, Issue Suppl_1 , Page AWP6-AWP6, February 1, 2025. Patients with increasing CT-CSVD scores were older (p<0.001), more likely to have hypertension (p<0.001), diabetes (p<0.001), coronary artery disease (p=0.044), and a higher baseline systolic blood pressure (p=0.037). 1.95, p = 0.019).Conclusion:This
Stroke, Volume 56, Issue Suppl_1 , Page AWP44-AWP44, February 1, 2025. These findings remained robust after adjusting for other VCID risk factors, such as age, diabetes, hyperlipidemia and hypertension (Table 1).Conclusion:Our However, the mechanism underlying this association remains poorly understood.
Stroke, Volume 56, Issue Suppl_1 , Page AWP293-AWP293, February 1, 2025. The HR was nonsignificant after adjustment for age, gender, race, hypertension, diabetes, hypercholesterolemia and smoking status, adjusted HR 1.33 The HR remained significant after adjustment for age, gender and race, adjusted HR 1.72 with a 95% CI of 1.17-2.51.
Stroke, Volume 56, Issue Suppl_1 , Page ATP182-ATP182, February 1, 2025. Baseline characteristics such as diabetes, hypertension, smoking, ipsilateral ICAD, etc. The etiology of AChA infarcts remains poorly understood. 29 patients had TEE, no of which identified etiology. The median age of the sample was 57.5 (IQR IQR of 13.5)
Stroke, Volume 56, Issue Suppl_1 , Page A141-A141, February 1, 2025. SPRINT originally randomized 9,361 hypertensive individuals without diabetes into two groups: intensive treatment (SBP<120 mmHg, n=4,678) and standard treatment (SBP<140 mmHg, n=4,683).
Stroke, Volume 56, Issue Suppl_1 , Page AWP328-AWP328, February 1, 2025. Migraine with aura(MwA) is associated with an increased risk of stroke and adverse vascular outcomes compared to those with migraine without aura (MwoA).
Stroke, Volume 56, Issue Suppl_1 , Page AWP137-AWP137, February 1, 2025. 1.66]), and comorbidities of diabetes (1.29 [1.18-1.41]), 1.41]), hypertension (1.15 [1.05-1.25]), The AIS patients in the LKWA>4.5 groups were more likely to be older >80 years (Odds Ratio=1.18 [95% Confidence Intervals:1.03-1.32]),
A study published in Nature Medicine evaluated the burden of type 2 diabetes and cardiovascular disease attributable to sugar sweetened beverages in 184 countries [1]. million cases of new type 2 diabetes was attributable to sugar sweetened beverages worldwide, which was 9.8% 2025 Jan 6. In 2020, 2.2 of incident cases.
Hypertension, Volume 82, Issue 1 , Page 136-148, January 1, 2025. We hypothesized that higher VOC exposure is associated with higher blood pressure and hypertension, among nonsmokers.METHODS:We included 4 cycles of data (20112018) of nonsmoking adults (n=4430) from the National Health and Nutrition Examination Survey.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content